WATSON 782 (Diethylpropion Extended-Release 75 mg)
Pill imprint WATSON 782 has been identified as Diethylpropion hydrochloride extended-release 75 mg.
Diethylpropion is used in the treatment of obesity and belongs to the drug classes anorexiants, CNS stimulants. There is no proven risk in humans during pregnancy. Diethylpropion 75 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
See also related documents.
- 75 mg
- 19.00 mm
- Elliptical / Oval
- Prescription only
|NDC Code||Manufacturer / Repackager|
|54569-0396||A-S Medication Solutions, LLC (repackager)|
|54868-1463||Physicians Total Care Inc (repackager)|
|66336-0689||Dispensing Solutions Inc. (repackager)|
|23490-5435||Palmetto State Pharmaceuticals Inc (repackager)|
|49999-0457||Lake Erie Medical and Surgical Supply (repackager)|
|21695-0876||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.
More about diethylpropion
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.